Information Journal Paper
APA:
Copy. (2017). FDA approval of tisagenlecleucel: promise and complexities of a $475000 cancer drug. Jama, 318(19), 1861-1862. SID. https://sid.ir/paper/718736/en
Vancouver:
Copy. FDA approval of tisagenlecleucel: promise and complexities of a $475000 cancer drug. Jama[Internet]. 2017;318(19):1861-1862. Available from: https://sid.ir/paper/718736/en
IEEE:
Copy, “FDA approval of tisagenlecleucel: promise and complexities of a $475000 cancer drug,” Jama, vol. 318, no. 19, pp. 1861–1862, 2017, [Online]. Available: https://sid.ir/paper/718736/en